1. Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States. (2nd November 2017) Authors: Hunt, B.; McConnachie, C.C.; Gamble, C.; Dang-Tan, T. Journal: Journal of medical economics Issue: Volume 20:Number 11(2017) Page Start: 1117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗